Kesmalea Therapeutics, a biopharmaceutical company developing a pipeline of novel therapeutics founded on the ability to transform large protein degraders into small molecules, today announced the ...

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is ...

Alnylam Pharmaceuticals has strong growth potential, particularly with Amvuttra for ATTR-CM. Read why ALNY stock justifies a ...

Does creatine cause hair loss? If you’re worried that creatine supplements might cause baldness, check out the scientific ...

A drug sitting on pharmacy shelves could also help fight back against devastating brain diseases like Alzheimer’s. Researchers at the University of Cambridge have found that a medication typically ...

The low-carb, high-protein diet promotes rapid ... According to the plan, people can lose up to 8lbs during the first phase, followed by about 2lbs per week until reaching their ideal weight, which ...

Discover innovative solutions in advancing protein quality control, optimizing efficiency in high-throughput screening ...

These days, it seems like nearly everyone I talk to is either on Ozempic or knows someone who is. Ozempic is actually one ...

Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...

Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...

Project Title Fragment and structure-based hit generation platform for new malaria targets Collaboration Partners 1.